232 related articles for article (PubMed ID: 20948997)
1. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
[TBL] [Abstract][Full Text] [Related]
2. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.
Zamakhchari M; Wei G; Dewhirst F; Lee J; Schuppan D; Oppenheim FG; Helmerhorst EJ
PLoS One; 2011; 6(9):e24455. PubMed ID: 21957450
[TBL] [Abstract][Full Text] [Related]
3. Gluten hydrolyzing activity of Bacillus spp isolated from sourdough.
Rashmi BS; Gayathri D; Vasudha M; Prashantkumar CS; Swamy CT; Sunil KS; Somaraja PK; Prakash P
Microb Cell Fact; 2020 Jun; 19(1):130. PubMed ID: 32532261
[TBL] [Abstract][Full Text] [Related]
4. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
[TBL] [Abstract][Full Text] [Related]
5. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.
Fernandez-Feo M; Wei G; Blumenkranz G; Dewhirst FE; Schuppan D; Oppenheim FG; Helmerhorst EJ
Clin Microbiol Infect; 2013 Sep; 19(9):E386-94. PubMed ID: 23714165
[TBL] [Abstract][Full Text] [Related]
6. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ
Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519
[TBL] [Abstract][Full Text] [Related]
7. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
8. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.
Wei G; Tian N; Siezen R; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G571-80. PubMed ID: 27469368
[TBL] [Abstract][Full Text] [Related]
9. Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.
Tian N; Wei G; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G769-76. PubMed ID: 25147233
[TBL] [Abstract][Full Text] [Related]
10. The human digestive tract has proteases capable of gluten hydrolysis.
Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB
Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325
[TBL] [Abstract][Full Text] [Related]
11. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
[TBL] [Abstract][Full Text] [Related]
12. Human small-intestinal gluten-degrading bacteria and its potential implication in celiac disease.
Dewala S; Bodkhe R; Nimonkar Y; Prakash OM; Ahuja V; Makharia GK; Shouche YS
J Biosci; 2023; 48():. PubMed ID: 37309172
[TBL] [Abstract][Full Text] [Related]
13. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
14. Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.
Tian N; Leffler DA; Kelly CP; Hansen J; Marietta EV; Murray JA; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G910-7. PubMed ID: 26505973
[TBL] [Abstract][Full Text] [Related]
15. Commensal Bacterium
Wei G; Darwish G; Oppenheim FG; Schuppan D; Helmerhorst EJ
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276655
[TBL] [Abstract][Full Text] [Related]
16. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
[TBL] [Abstract][Full Text] [Related]
17. Selection of Gut-Resistant Bacteria and Construction of Microbial Consortia for Improving Gluten Digestion under Simulated Gastrointestinal Conditions.
De Angelis M; Siragusa S; Vacca M; Di Cagno R; Cristofori F; Schwarm M; Pelzer S; Flügel M; Speckmann B; Francavilla R; Gobbetti M
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808622
[TBL] [Abstract][Full Text] [Related]
18. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
Arentz-Hansen H; McAdam SN; Molberg Ø; Fleckenstein B; Lundin KE; Jørgensen TJ; Jung G; Roepstorff P; Sollid LM
Gastroenterology; 2002 Sep; 123(3):803-9. PubMed ID: 12198706
[TBL] [Abstract][Full Text] [Related]
19. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
Qiao SW; Bergseng E; Molberg O; Jung G; Fleckenstein B; Sollid LM
J Immunol; 2005 Jul; 175(1):254-61. PubMed ID: 15972656
[TBL] [Abstract][Full Text] [Related]
20. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
